Immunome Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Immunome Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q2 2025.
  • Immunome Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$46.5M, a 16.2% decline year-over-year.
  • Immunome Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$225M, a 17.3% increase year-over-year.
  • Immunome Inc. annual Operating Income (Loss) for 2024 was -$306M, a 179% decline from 2023.
  • Immunome Inc. annual Operating Income (Loss) for 2023 was -$110M, a 197% decline from 2022.
  • Immunome Inc. annual Operating Income (Loss) for 2022 was -$36.9M, a 46.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$225M -$46.5M -$6.47M -16.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 -$218M -$44.6M +$87.7M +66.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 -$306M -$83M +$11.7M +12.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-19
Q3 2024 -$317M -$50.5M -$45.9M -990% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$272M -$40M -$34.2M -593% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 -$237M -$132M -$128M -2859% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 -$110M -$94.7M -$86.9M -1116% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-19
Q3 2023 -$22.7M -$4.63M +$3.9M +45.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$26.6M -$5.77M +$3.15M +35.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$29.7M -$4.47M +$7.18M +61.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$36.9M -$7.79M +$57K +0.73% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$37M -$8.53M -$811K -10.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$36.1M -$8.93M -$3.19M -55.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$33M -$11.7M -$7.76M -199% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$25.2M -$7.84M -$3.77M -92.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$21.4M -$7.72M -$4.91M -174% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$16.5M -$5.74M -$3.03M -111% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$13.5M -$3.9M -$1.24M -46.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$12.3M -$4.07M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$2.82M -$98K -3.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.72M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$2.66M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 -$2.72M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.